Assessment cycle 2026 Q3 — page 11
Documents ratified in the 2026 Q3 assessment cycle, which ran from 1 July 2026 to 30 September 2026 and was ratified on 18 September 2026.
Documents ratified
-
External reviewer, sleep medicine. Endocrine surgery service
30 Jul 2026 -
Submitted-evidence contributor, public health. Academic clinical pharmacology unit
30 Jul 2026 -
Comment-period correspondent, paediatric endocrinology. Health-technology assessment agency
30 Jul 2026 -
Comment-period correspondent, cardiovascular outcomes. Primary-care research network
30 Jul 2026 -
Specialist adviser, pharmacovigilance. Academic nephrology unit
30 Jul 2026 -
Submitted-evidence contributor, clinical pharmacology. Academic nephrology unit
30 Jul 2026 -
Comment-period correspondent, patient and public involvement. Regulatory affairs, generic medicines sector
30 Jul 2026 -
External reviewer, endocrinology. Health-technology assessment agency
30 Jul 2026 -
Comment-period correspondent, nephrology. University department of medicinal chemistry
30 Jul 2026 -
Comment-period correspondent, sleep medicine. Academic nephrology unit
30 Jul 2026 -
External reviewer, microbiological quality. National pharmacovigilance centre
30 Jul 2026 -
Submitted-evidence contributor, health-technology assessment. University department of hepatology
30 Jul 2026 -
External reviewer, public health. Academic clinical pharmacology unit
30 Jul 2026 -
Comment-period correspondent, pharmacovigilance. Public-sector clinical trials unit
30 Jul 2026 -
External reviewer, patient and public involvement. Hospital microbiology and endotoxin testing service
30 Jul 2026 -
Comment-period correspondent, analytical chemistry. University department of medicinal chemistry
30 Jul 2026 -
External reviewer, health-technology assessment. University teaching hospital, department of endocrinology
30 Jul 2026 -
External reviewer, microbiological quality. Regulatory affairs, generic medicines sector
30 Jul 2026 -
Comment-period correspondent, clinical biochemistry. Academic nephrology unit
30 Jul 2026 -
Submitted-evidence contributor, evidence synthesis. University department of public health
30 Jul 2026 -
Comment-period correspondent, endocrinology. Health-technology assessment agency
30 Jul 2026 -
Submitted-evidence contributor, patient and public involvement. Independent analytical consultancy
30 Jul 2026 -
External reviewer, clinical pharmacology. ISO/IEC 17025-accredited contract testing laboratory
30 Jul 2026 -
Submitted-evidence contributor, public health. Community pharmacy practice, doctoral candidate
30 Jul 2026 -
Comment-period correspondent, paediatric endocrinology. University department of pharmacy practice
30 Jul 2026 -
Comment-period correspondent, pharmacy practice. Independent evidence-synthesis consultancy
30 Jul 2026 -
External reviewer, analytical chemistry. Community pharmacy practice, doctoral candidate
30 Jul 2026 -
External reviewer, clinical biochemistry. Endocrine surgery service
30 Jul 2026 -
Submitted-evidence contributor, toxicology. Sleep and respiratory medicine service
30 Jul 2026 -
Specialist adviser, endocrinology. University teaching hospital, department of endocrinology
30 Jul 2026 -
External reviewer, nephrology. University department of medicinal chemistry
30 Jul 2026 -
Comment-period correspondent, clinical pharmacology. Endocrine surgery service
30 Jul 2026 -
External reviewer, patient and public involvement. National pharmacovigilance centre
30 Jul 2026 -
Comment-period correspondent, paediatric endocrinology. University teaching hospital, department of endocrinology
30 Jul 2026 -
Submitted-evidence contributor, regulatory science. Academic peptide-chemistry group
30 Jul 2026 -
External reviewer, toxicology. Hospital microbiology and endotoxin testing service
30 Jul 2026 -
Comment-period correspondent, hepatology. Academic sports-medicine and anti-doping laboratory
30 Jul 2026 -
External reviewer, analytical chemistry. Metabolic medicine service, tertiary centre
30 Jul 2026 -
Submitted-evidence contributor, pharmacy practice. Regional hospital pharmacy department
30 Jul 2026 -
Comment-period correspondent, cardiovascular outcomes. National medicines information service
30 Jul 2026
page 11 of 14